Ferroptosis in platelet homeostasis: redox mechanisms, pathophysiological relevance, and therapeutic implications

Platelet homeostasis depends on coordinated thrombopoiesis in the bone marrow and adequate platelet survival in the circulation. Ferroptosis, an iron-dependent form of regulated cell death driven by phospholipid peroxidation and collapse of antioxidant defenses, may influence both processes. This review summarizes current evidence linking ferroptosis to platelet production and injury. Evidence from studies of hematopoietic stem cells and an in vitro iron-overload model of megakaryopoiesis suggests that ferroptosis-related stress may impair hematopoietic stem/progenitor cell fitness and megakaryocyte differentiation and maturation, thereby reducing platelet production. In parallel, under hemolytic and severe oxidative stress conditions, heme/hemin-driven injury may promote platelet activation, membrane destabilization, and death, contributing to peripheral platelet loss and thrombo-inflammatory complications. However, the ROS accumulation, lipid peroxidation, glutathione depletion, mitochondrial dysfunction, and pharmacological protection reported in circulating platelets do not individually establish ferroptosis, particularly because oxidative injury, inflammatory signaling, and other cell-death pathways may overlap. We further discuss the molecular basis of ferroptosis, focusing on iron handling, lipid peroxidation, and antioxidant defense, with particular emphasis on the extent to which these mechanisms have been demonstrated in megakaryocytes and mature platelets or remain inferred from other cell types. Pharmacological interventions investigated in megakaryocyte- and platelet-related models are also discussed, together with their potential relevance and mechanistic limitations. Overall, available evidence suggests that ferroptosis-related processes may contribute to platelet homeostasis at both the bone marrow and circulatory levels, although the strength of mechanistic evidence differs between these compartments. Integrating cell-specific molecular profiling with functional and mechanistic validation may help resolve the regulatory basis of ferroptosis across hematopoietic stem/progenitor cells, megakaryocytes, and circulating platelets and identify potential therapeutic opportunities for platelet-related disorders.

Authors

Publication Details

Journal
Molecular Medicine
Published
2026-11-20
DOI
https://doi.org/10.1186/s10020-026-01707-x
Primary Topic
Platelet Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Ferroptosis in platelet homeostasis: redox mechanisms, pathophysiological relevance, and therapeutic implications

Shuang Dai, Qi Wang, Tianci Hu, Qiyang Cheng et al.
Molecular Medicine
Platelet Disorders and Treatments
article

Ferroptosis in platelet homeostasis: redox mechanisms, pathophysiological relevance, and therapeutic implications

Shuang Dai, Qi Wang, Tianci Hu, Qiyang Cheng, Xuejing Qiang, Tianhao Li, Mengying Lei, Siyu Huang, Min Wu, Xinyu Liu, Sirui Li, Peng Chen, Long Wang, Chenxin Deng, Jianming Wu
article en

Abstract

Platelet homeostasis depends on coordinated thrombopoiesis in the bone marrow and adequate platelet survival in the circulation. Ferroptosis, an iron-dependent form of regulated cell death driven by phospholipid peroxidation and collapse of antioxidant defenses, may influence both processes. This review summarizes current evidence linking ferroptosis to platelet production and injury. Evidence from studies of hematopoietic stem cells and an in vitro iron-overload model of megakaryopoiesis suggests that ferroptosis-related stress may impair hematopoietic stem/progenitor cell fitness and megakaryocyte differentiation and maturation, thereby reducing platelet production. In parallel, under hemolytic and severe oxidative stress conditions, heme/hemin-driven injury may promote platelet activation, membrane destabilization, and death, contributing to peripheral platelet loss and thrombo-inflammatory complications. However, the ROS accumulation, lipid peroxidation, glutathione depletion, mitochondrial dysfunction, and pharmacological protection reported in circulating platelets do not individually establish ferroptosis, particularly because oxidative injury, inflammatory signaling, and other cell-death pathways may overlap. We further discuss the molecular basis of ferroptosis, focusing on iron handling, lipid peroxidation, and antioxidant defense, with particular emphasis on the extent to which these mechanisms have been demonstrated in megakaryocytes and mature platelets or remain inferred from other cell types. Pharmacological interventions investigated in megakaryocyte- and platelet-related models are also discussed, together with their potential relevance and mechanistic limitations. Overall, available evidence suggests that ferroptosis-related processes may contribute to platelet homeostasis at both the bone marrow and circulatory levels, although the strength of mechanistic evidence differs between these compartments. Integrating cell-specific molecular profiling with functional and mechanistic validation may help resolve the regulatory basis of ferroptosis across hematopoietic stem/progenitor cells, megakaryocytes, and circulating platelets and identify potential therapeutic opportunities for platelet-related disorders.

Molecular Medicine
Platelet Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon